FMK-MEA
FMK-MEA is a potent and selective p90 Ribosomal S6 Kinase (RSK) inhibitor.
Product Specifications
CAS Number
[1414811-15-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Ribosomal S6 Kinase (RSK)
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/FMK-MEA.html
Concentration
10mM
Purity
99.40
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FCC(C1=C(C2=CC=C(C)C=C2)C3=C(N)N=CN=C3N1CCCNCCOC)=O
Molecular Formula
C21H26FN5O2
Molecular Weight
399.46
Precautions
H302, H315, H319, H335
References & Citations
[1]Li D, et al. The prometastatic ribosomal S6 kinase 2-cAMP response element-binding protein (RSK2-CREB) signaling pathway up-regulates the actin-binding protein fascin-1 to promote tumor metastasis. J Biol Chem. 2013 Nov 8;288 (45) :32528-38.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RSK2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
411579-01 250 µg
[1 (Z),2E,8[2S,3S (1S,2S) ]]- 5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3- (2-hydroxy-1-methylpropyl) oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid 9-Methoxy-9-oxo-5-nonenyl Ester
Ask
View Details 411579-02 500 µg
[1 (Z),2E,8[2S,3S (1S,2S) ]]- 5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3- (2-hydroxy-1-methylpropyl) oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid 9-Methoxy-9-oxo-5-nonenyl Ester
Ask
View Details